Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment

Martin W. Schoen, MDMPH, Peter Georgantopoulos, MS, Nagasai S Yalavarthi, BS, Charles L. Bennett, MD PhD

Blood (2019) 134 (Supplement_1): 2135.

https://doi.org/10.1182/blood-2019-121770

Published: 2019

Journal Articles

A Novel Targeted Approach to Achieve Immune System Reset: CD45-Targeted Antibody Drug Conjugates Enable Autologous HSCT, Ameliorate Disease in Autoimmune Models, Potently Kill Human Immune Cells from Normal Donors and MS Patients, and Achieve Immune Depletion in Non-Human Primates (NHP)

Geoff O Gillard, Jennifer L Proctor, BS, Melissa L. Brooks, BS, Tahirih L Lamothe, BS, Sharon L. Hyzy, MS, Oliver Mikse, Sean McDonough, Rahul Palchaudhuri, PhD, Anjali Bhat, MS, Ganapathy N. Sarma, PhD, Prashant Bhattarai, Pranoti Sawant, MS, Bradley R Pearse, PhD, Charlotte F. Mcdonough, PhD, Anthony E. Boitano, PhD, Michael P. Cooke, PhD

Blood (2019) 134 (Supplement_1): 3208.

https://doi.org/10.1182/blood-2019-130752

Published: 2019

Journal Articles

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Kai Sun, MD, Xuejun Zhang, MD, Zhen Wang, MD, Yuqing Chen, MD, Lei Zhang, MD, Wei Cheng, MD, Mingyue Shi, MD, Lei Huo, MD, Yanliang Bai, MD, Xiaona Niu, MD, Honggang Guo, MD, Jing Yang, MD, Chunrong Tong, MD, AlexH Chang, MD, PhD

Blood (2018) 132 (Supplement 1): 4275.

https://doi.org/10.1182/blood-2018-99-115768

Published: 2018

Journal Articles

Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine or Bendamustine

Martin W. Schoen, MD MPH, Kristen M. Sanfilippo, MD MPHS, Theodore S. Thomas, MD MPHS, Suhong Luo, MS, Kahee A. Mohammed, MD MPH, Kenneth R. Carson, MD PhD

Blood (2017) 130 (Supplement 1): 2174.

https://doi.org/10.1182/blood.V130.Suppl_1.2174.2174

Published: 2017

Journal Articles

Aplastic Anemia in the Context of Hemolytic Paroxysmal Nocturnal Hemoglobinuria: Feasibility of Antibody-Based Intensive Immunosuppression during Eculizumab Treatment

Simona Pagliuca, MD, Flore Sicre de Fontbrune, MD, Serena Marotta, MD, Anna Paola Iori, Marie Robin, MD PhD, Gérard Socié, MD PhD, Regis Peffault de Latour, MD PhD, Antonio M Risitano, MD PhD

Blood (2016) 128 (22): 5074.

https://doi.org/10.1182/blood.V128.22.5074.5074

Published: 2016

Journal Articles

Donor Lymphocyte Infusions Correct Deficiency of Naive T Cells and Improve T-Cell Competence after Allogeneic Haematopoietic Stem Cell Transplantation with Lymphocyte Depletion

Monera Al Rukhayes, Victoria T Potter, Pilar Perez-Abellan, Jesus Feliu, Lajos Floro, Ruby Quartey-Papafio, Farzin Farzaneh, Pramila Krishnamurthy, Jennifer Clay, Carmel Rice, Antonio Pagliuca, MBBS MA FRCP FRCPath, Ghulam J Mufti, Linda D Barber

Blood (2016) 128 (22): 2233.

https://doi.org/10.1182/blood.V128.22.2233.2233

Published: 2016

Journal Articles

Exploring Relationships of Exposure, Pharmacodynamic Changes and Gene Expression to Clinical Outcome in Adults with Acute Lymphoblastic Leukemia Receiving Inotuzumab Ozogamicin

Luke Fostvedt, A. Douglas Laird, Jean-Claude Marshall, Sherry Li, Joseph P. Boni, PhD BS

Blood (2015) 126 (23): 3698.

https://doi.org/10.1182/blood.V126.23.3698.3698

Published: 2015

Journal Articles

Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory CLL and MCL; Results of a Phase II Trial

Jeff P. Sharman, MD, Charles M. Farber, MD PhD, Daruka Mahadevan, MD PhD, Marshall T. Schreeder, MD, Heather D. Brooks, MD, Kathryn S. Kolibaba, MD, Suzanne R. Fanning, DO, Leonard M. Klein, MD, Peter Sportelli, Hari P. Miskin, MS, Michael S. Weiss, Daniel R. Greenwald, MD

Blood (2014) 124 (21): 4679.

https://doi.org/10.1182/blood.V124.21.4679.4679

Published: 2014

Journal Articles

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Brian C. Shaffer, MD, Andrew Flynn, David Moorshead, Zach Powell, Jennifer Hsu, RN, Rachel B Salit, MD, Frances T. Hakim, PhD, Ronald E. Gress, MD, Michael Bishop, MD, Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD

Blood (2013) 122 (21): 4580.

https://doi.org/10.1182/blood.V122.21.4580.4580

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin´s Lymphoma

Maria Marta Rivas, MD, Mariano Berro, MD, Sebastian Yantorno, MD, Maria Virginia Prates, MD, Jorge H Milone, Ana Lisa Basquiera, Adriana Berreta, MD, Juan Garcia, MD, Guillermina Remaggi, MD, Juliana Martinez Rolon, MD, Jorge Arbelbide, MD, Monica Makiya, MD, Eduardo Dibar, Alejandro Requejo, MD, Leonardo Julio Feldman, Sr., MD, Vera Milovic, Maria Cecilia Foncuberta, MD, Rubén Burgos, MD, Gustavo Daniel Kusminsky, MD

Blood (2013) 122 (21): 5511.

https://doi.org/10.1182/blood.V122.21.5511.5511

Published: 2013

Journal Articles

Impact of the Conditioning Chemotherapy On Outcomes in Adoptive T Cell Therapy: Results From a Phase I Clinical Trial of Autologous CD19-Targeted T Cells for Patients with Relapsed CLL

Jae H. Park, MD, Isabelle Rivière, PhD, Xiuyan Wang, PhD, Jolanta Stefanski, Qing He, Clare Taylor, MSc, Malgorzata Olszewska, Teresa Wasielewska, Shirley Bartido, PhD, Marco L Davila, MD, PhD, Yvette Bernal, Nicole Lamanna, MD, Ariela Noy, MD, Michel Sadelain, MD, PhD, Renier J Brentjens, MD, PhD

Blood (2012) 120 (21): 1797.

https://doi.org/10.1182/blood.V120.21.1797.1797

Published: 2012

Journal Articles

Failure of Erythropoiesis and Megakaryocytopoiesis in RASA3 Mutant Scat Mice

Lionel Blanc, PhD, Babette Gwynn, MS, Steven L. Ciciotte, MS, Luanne L. Peters, PhD

Blood (2011) 118 (21): 680.

https://doi.org/10.1182/blood.V118.21.680.680

Published: 2011

Journal Articles

Multicentre Phase I Study with an 8-Dose Regimen of Single Agent Anti-CD20 Monoclonal Antibody LFB-R603 in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)

Bruno Cazin, MD, Stéphane Leprêtre, MD, Bertrand Coiffier, Thérèse Aurran, MD, Guillaume Cartron, MD, PhD, Pierre Feugier, MD, PhD, Oana Brehar, MD, Alain Sadoun, MD, Fédéric Segaud, Vincent Ribrag, MD

Blood (2011) 118 (21): 2862.

https://doi.org/10.1182/blood.V118.21.2862.2862

Published: 2011

Journal Articles

Hodgkin Lymphoma: 20 Years Experience From a Single Brazilian Institution

Camila C.G. Linardi, MD; PhD., Luis Fernando Pracchia, MD., Rodrigo Dolphini Velasques, MD., Claudia Bitti Barroso, MD, Valeria Buccheri, MD; PhD.

Blood (2011) 118 (21): 3153.

https://doi.org/10.1182/blood.V118.21.3153.3153

Published: 2011

Journal Articles

Pilot Randomized Trial Comparing the Effects of Alemtuzumab and Cyclosporine Versus Tacrolimus, Methotrexate and Sirolimus on Graft Versus Host Disease Prevention, Engraftment and Immune Reconstitution After Reduced Intensity Unrelated Donor Transplantation.

Rachel B. Salit, MD, Steven Z. Pavletic, MD, Daniel H. Fowler, MD, Jennifer Wilder, RN, Kelly Bryant, RN, Seth M. Steinberg, PhD, Frances T. Hakim, PhD, Michael R. Bishop, MD

Blood (2010) 116 (21): 1245.

https://doi.org/10.1182/blood.V116.21.1245.1245

Published: 2010

Journal Articles

Use of Targeted Lymphocyte Depletion as a Personalized Approach to Improve Engraftment and Disease Control Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Unrelated Donors

Rachel B. Salit, MD, Steven Z. Pavletic, MD, Daniel H. Fowler, MD, Jennifer Wilder, RN, Kelly Bryant, RN, Seth M. Steinberg, PhD, Frances T. Hakim, PhD, Michael R. Bishop, MD

Blood (2010) 116 (21): 3530.

https://doi.org/10.1182/blood.V116.21.3530.3530

Published: 2010

Journal Articles

Allogeneic Hematopoetic Transplantation for CLL: Results of Combination Chemotherapy as Pre-Transplant Targeted Lymphocyte Depletion on Disease Response, Donor Chimerism, and Transplantation Outcomes.

Brian C Shaffer, MD, Marko Modric, David Liewehr, MS, Maryalice Stetler-Stevenson, MD, PhD, Diane C Arthur, MD, Seth Steinberg, PhD, Frances T Hakim, PhD, Kelly Bryant, Jeanne Odom, Paula Layton, BSN, Rachel B Salit, MD, Christoph Rader, PhD, Ronald E Gress, MD, Daniel H Fowler, MD, Michael R Bishop, MD, Steven Z Pavletic, MD

Blood (2010) 116 (21): 3476.

https://doi.org/10.1182/blood.V116.21.3476.3476

Published: 2010

Journal Articles

A Phase I study of LFB-R603, a Novel Anti-CD20 Antibody, in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)

Guillaume Cartron, MD, PhD, Bruno Cazin, MD, Bertrand Coiffier, MD, PhD, Stéphane Leprêtre, MD, Pierre Feugier, MD, PhD, Thérèse Aurran, MD, Guylène Chartier, Alain Sadoun, MD, Vincent Ribrag, MD

Blood (2010) 116 (21): 2447.

https://doi.org/10.1182/blood.V116.21.2447.2447

Published: 2010

Journal Articles

Clinicopathological Features of Nodular Sclerosis-Type Classical Hodgkin Lymphoma In the Elderly: Multicenter Study of Hodgkin Lymphoma In Japan

Naoko Asano, MD, Tomohiro Kinoshita, MD, PhD, Koichi Ohshima, MD, Tadashi Yoshino, MD, Nozomi Niitsu, MD, Norifumi Tsukamoto, MD, PhD, Kaoru Hirabayashi, MD, Koji Izutsu, MD, Yasuo Morishima, MD, PhD, Tadashi Matsushita, MD, PhD, Shigeo Nakamura, MD

Blood (2010) 116 (21): 2677.

https://doi.org/10.1182/blood.V116.21.2677.2677

Published: 2010

Journal Articles

Comparison of Clinical Outcomes and Day 30 Lymphocyte Recovery Between Two aGVHD Prophylaxis Regimens In Matched Unrelated Hematopoietic Stem Cell Transplant (MUD) Patients

Zartash Gul, MD, Mustafa Abdul-Hussein, MD, Ivo Ditah, MD, Joseph P. Uberti, MD, PhD, Muneer H. Abidi, MD, Lois Ayash, MD, Lawrence G. Lum, MD, DSC, Voravit Ratanatharathorn, MD, Zaid Al-Kadhimi, MD

Blood (2010) 116 (21): 2340.

https://doi.org/10.1182/blood.V116.21.2340.2340

Published: 2010

NARROW

Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment

A Novel Targeted Approach to Achieve Immune System Reset: CD45-Targeted Antibody Drug Conjugates Enable Autologous HSCT, Ameliorate Disease in Autoimmune Models, Potently Kill Human Immune Cells from Normal Donors and MS Patients, and Achieve Immune Depletion in Non-Human Primates (NHP)

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine or Bendamustine

Aplastic Anemia in the Context of Hemolytic Paroxysmal Nocturnal Hemoglobinuria: Feasibility of Antibody-Based Intensive Immunosuppression during Eculizumab Treatment

Donor Lymphocyte Infusions Correct Deficiency of Naive T Cells and Improve T-Cell Competence after Allogeneic Haematopoietic Stem Cell Transplantation with Lymphocyte Depletion

Exploring Relationships of Exposure, Pharmacodynamic Changes and Gene Expression to Clinical Outcome in Adults with Acute Lymphoblastic Leukemia Receiving Inotuzumab Ozogamicin

Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory CLL and MCL; Results of a Phase II Trial

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin´s Lymphoma

Impact of the Conditioning Chemotherapy On Outcomes in Adoptive T Cell Therapy: Results From a Phase I Clinical Trial of Autologous CD19-Targeted T Cells for Patients with Relapsed CLL

Failure of Erythropoiesis and Megakaryocytopoiesis in RASA3 Mutant Scat Mice

Multicentre Phase I Study with an 8-Dose Regimen of Single Agent Anti-CD20 Monoclonal Antibody LFB-R603 in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)

Hodgkin Lymphoma: 20 Years Experience From a Single Brazilian Institution

Pilot Randomized Trial Comparing the Effects of Alemtuzumab and Cyclosporine Versus Tacrolimus, Methotrexate and Sirolimus on Graft Versus Host Disease Prevention, Engraftment and Immune Reconstitution After Reduced Intensity Unrelated Donor Transplantation.

Use of Targeted Lymphocyte Depletion as a Personalized Approach to Improve Engraftment and Disease Control Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Unrelated Donors

Allogeneic Hematopoetic Transplantation for CLL: Results of Combination Chemotherapy as Pre-Transplant Targeted Lymphocyte Depletion on Disease Response, Donor Chimerism, and Transplantation Outcomes.

A Phase I study of LFB-R603, a Novel Anti-CD20 Antibody, in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)

Clinicopathological Features of Nodular Sclerosis-Type Classical Hodgkin Lymphoma In the Elderly: Multicenter Study of Hodgkin Lymphoma In Japan

Comparison of Clinical Outcomes and Day 30 Lymphocyte Recovery Between Two aGVHD Prophylaxis Regimens In Matched Unrelated Hematopoietic Stem Cell Transplant (MUD) Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only